Literature DB >> 10342791

Effects of interferon on circadian changes in blood pressure and heart rate variability in patients with chronic hepatitis.

M Fukuhara1, K Matsumura, S Ohmori, T Yanai, Y Tsubota, I Abe, M Fujishima.   

Abstract

We have determined the effects of interferon therapy on circadian changes in blood pressure and heart rate variability in normotensive hospitalized patients with chronic active hepatitis. Body temperature and pulse rate increased for the initial few days of interferon therapy without significant change in casual or ambulatory blood pressure. Interferon therapy failed to elicit any significant changes in the power spectrum of R-R intervals. In addition, urinary excretion of norepinephrine did not differ between before and during the therapy. These results suggest that interferon therapy caused transient increases in body temperature and pulse rate, but that it did not change either sympathetic or parasympathetic outflow, or the circadian rhythm of blood pressure and heart rate variability, in normotensive subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342791     DOI: 10.1016/s0895-7061(98)00252-0

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

1.  Therapy with TLR7 agonists induces lymphopenia: correlating pharmacology to mechanism in a mouse model.

Authors:  Hannah Perkins; Tansi Khodai; Houria Mechiche; Peter Colman; Frances Burden; Carl Laxton; Nigel Horscroft; Tom Corey; Deborah Rodrigues; Jaiessh Rawal; Jonathan Heyen; Mark Fidock; Mike Westby; Helen Bright
Journal:  J Clin Immunol       Date:  2012-04-05       Impact factor: 8.317

2.  Circulating tumoral cells lack circadian-rhythm in hospitalized metastasic breast cancer patients.

Authors:  José Angel García-Sáenz; Miguel Martín; Marisa Maestro; Marta Vidaurreta; Silvia Veganzones; Laura Villalobos; Laura Rodríguez-Lajusticia; Sara Rafael; María Teresa Sanz-Casla; Antonio Casado; Javier Sastre; Manuel Arroyo; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2006-11       Impact factor: 3.405

3.  Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System.

Authors:  Reda Biomy; Mohamed Abdelshafy; Ahmed Abdelmonem; Hesham Abu-Elenin; George Ghaly
Journal:  Clin Med Insights Cardiol       Date:  2017-06-22

4.  Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring.

Authors:  Ahmed Mohamed El Missiri; Mona Mostafa Rayan; Mohamed Medhat Awad; Ahmed Ibrahim El Desoky
Journal:  Egypt Heart J       Date:  2020-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.